Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 062357/0203 | |
| Pages: | 5 |
| | Recorded: | 01/12/2023 | | |
| Attorney Dkt #: | 117103 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
11
|
|
|
|
Patent #:
|
|
Issue Dt:
|
01/21/2020
|
Application #:
|
15516918
|
Filing Dt:
|
04/05/2017
|
|
Publication #:
|
|
Pub Dt:
|
06/21/2018
| | | | |
|
Title:
|
HSP70-Derived Peptide, Pharmaceutical Composition for Treating or Preventing Cancer Using Same, Immunity Inducer, and Method for Producing Antigen Presenting Cell
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
01/07/2020
|
Application #:
|
15556694
|
Filing Dt:
|
09/22/2017
|
|
Publication #:
|
|
Pub Dt:
|
04/19/2018
| | | | |
|
Title:
|
PEPTIDE DERIVED FROM GPC3, PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF CANCER USING THE SAME, IMMUNITY INDUCER, AND METHOD FOR PRODUCING ANTIGEN-PRESENTING CELLS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/24/2020
|
Application #:
|
15564604
|
Filing Dt:
|
10/05/2017
|
|
Publication #:
|
|
Pub Dt:
|
03/15/2018
| | | | |
|
Title:
|
METHOD FOR TREATING CANCER BY ADMINSTERING POLY I:C AND LAG-3-IgG FUSION PROTEIN
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
03/17/2020
|
Application #:
|
16185734
|
Filing Dt:
|
11/09/2018
|
|
Publication #:
|
|
Pub Dt:
|
02/28/2019
| | | | |
|
Title:
|
PEPTIDE DERIVED FROM GPC3, PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF CANCER USING SAME, IMMUNITY INDUCER, AND METHOD FOR PRODUCING ANTIGEN-PRESENTING CELLS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
04/05/2022
|
Application #:
|
16341415
|
Filing Dt:
|
04/11/2019
|
|
Publication #:
|
|
Pub Dt:
|
02/06/2020
| | | | |
|
Title:
|
METHOD FOR TREATING CANCER BY ADMINISTERING A TOLL-LIKE RECEPTOR AGONIST AND LAG-3 IgG FUSION PROTEIN
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
04/19/2022
|
Application #:
|
16715758
|
Filing Dt:
|
12/16/2019
|
|
Publication #:
|
|
Pub Dt:
|
04/23/2020
| | | | |
|
Title:
|
HSP70-DERIVED PEPTIDE, PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING CANCER USING SAME, IMMUNITY INDUCER, AND METHOD FOR PRODUCING ANTIGEN-PRESENTING CELL
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
12/29/2020
|
Application #:
|
16782544
|
Filing Dt:
|
02/05/2020
|
|
Publication #:
|
|
Pub Dt:
|
05/21/2020
| | | | |
|
Title:
|
PEPTIDE DERIVED FROM GPC3, PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF CANCER USING SAME, IMMUNITY INDUCER, AND METHOD FOR PRODUCING ANTIGEN-PRESENTING CELLS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/08/2022
|
Application #:
|
16935534
|
Filing Dt:
|
07/22/2020
|
|
Publication #:
|
|
Pub Dt:
|
01/07/2021
| | | | |
|
Title:
|
COMPOSITION COMPRISING POLY I:C AND LAG-3-IGG FUSION PROTEIN
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
09/19/2023
|
Application #:
|
17680719
|
Filing Dt:
|
02/25/2022
|
|
Publication #:
|
|
Pub Dt:
|
06/09/2022
| | | | |
|
Title:
|
MEDICINE FOR TREATING CANCER BY ADMINISTERING A TOLL-LIKE RECEPTOR AGONIST AND LAG-3 IgG FUSION PROTEIN
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17693046
|
Filing Dt:
|
03/11/2022
|
|
Publication #:
|
|
Pub Dt:
|
06/23/2022
| | | | |
|
Title:
|
HSP70-DERIVED PEPTIDE, PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING CANCER USING SAME, IMMUNITY INDUCER, AND METHOD FOR PRODUCING ANTIGEN PRESENTING CELL
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17780396
|
Filing Dt:
|
05/26/2022
|
|
Publication #:
|
|
Pub Dt:
|
12/22/2022
| | | | |
|
Title:
|
PHARMACEUTICAL COMPOSITION
|
|
|
Assignee
|
|
|
|
|
| 7-1, SHIBA 5-CHOME |
| MINATO-KU, TOKYO, JAPAN 108-8001 |
|
|
Correspondence name and address
|
| |
KRISTEL SCHORR
|
| |
FOLEY & LARDNER LLP
|
| |
3000 K STREET NW SUITE 500
|
| |
WASHINGTON, DC 20007-5109
|
Search Results as of:
05/09/2024 09:50 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
